Castle Biosciences COO Sells $390K in Company Stock
CASTLE BIOSCIENCES INC
Subscribe to track CSTL
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Castle Biosciences COO Sells $390K in Company Stock
Company: CASTLE BIOSCIENCES INC (CSTL) Form: 4/A | Filed: 2025-11-04 Significance: Low
Insider: Oelschlager Kristen M Title: Chief Operating Officer | Relationship: Officer
Transaction: • Type: Sale • Shares: 18,007 • Price: $21.69 • Value: $390,432 • Owned After: 153,861 (Direct & Indirect)
Key Insight: The COO sold shares valued at $390k, representing less than 0.1% of the company's shares outstanding. This amended filing corrects the ownership from direct to indirect.
Market Context: The transaction size is minor relative to the company's $740M market cap, indicating low market impact.
Comprehensive Analysis
SEC Filing Analysis: CASTLE BIOSCIENCES INC (CSTL)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The Chief Operating Officer, Kristen M. Oelschlager, executed an indirect sale of common stock valued at approximately $390,000.
- Market Impact: The transaction is of low materiality, representing a negligible percentage of the company's market capitalization and shares outstanding.
Company Information
| Field | Value |
|---|---|
| Company | CASTLE BIOSCIENCES INC |
| Ticker Symbol | CSTL |
| CIK | 0001447362 |
| Industry | SERVICES-MEDICAL LABORATORIES |
Insider Information
| Field | Value |
|---|---|
| Name | Oelschlager Kristen M |
| CIK | 0001856565 |
| Title/Position | Chief Operating Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4/A |
| Transaction Date | 2025-08-27 |
| Transaction Code | S (Sale) |
| Security Type | Common Stock |
| Shares Involved | 18,007 |
| Price Per Share | $21.69 |
| Total Value | $390,431.83 |
| Shares Owned After | 153,861 (Total Direct & Indirect) |
| Ownership Type | Indirect |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $390,431.83 |
| % of Market Cap | 0.053% |
| Shares Transacted | 18,007 |
| % of Shares Outstanding | 0.062% |
| Post-Transaction Ownership | 153,861 shares (0.53% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a company with a market capitalization of $740 million, this $390k sale is not financially significant.
- Ownership Concentration: The sale reduced the COO's holdings by approximately 10.5%, a minor adjustment to her overall position. Her remaining stake is 0.53% of all outstanding shares.
- Transaction Significance: The transaction falls well below the thresholds for moderate or high significance (<0.1% of market cap and <0.1% of shares outstanding).
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The sale is too small relative to the company's market capitalization and public float to have a meaningful impact on the stock price. It appears to be a routine diversification or liquidity event for the insider.
Volume & Sentiment
- Expected Volume Impact: Negligible. The transaction size is unlikely to influence trading volume.
- Sentiment Indicator: Neutral. This is a small, routine insider sale with no clear bearish signal.
Additional Context
Transaction Notes
- Special Circumstances: This Form 4/A was filed to amend a previous report, correcting the nature of the sale from direct to indirect (via The Fritz Shorter Trust) and updating the post-transaction holding amounts. The insider retains beneficial ownership and investment power over the trust's shares.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
